12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

  • Nuwellis NUWE shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today.
  • Bioventus BVS stock moved upwards by 28.87% to $5.16. The market value of their outstanding shares is at $329.0 million. The company's, Q1 earnings came out today.
  • Design Therapeutics DSGN stock rose 28.49% to $4.69. The market value of their outstanding shares is at $264.9 million.
  • Acutus Medical AFIB stock moved upwards by 24.11% to $0.13. The company's market cap stands at $3.9 million.
  • Oragenics OGEN shares moved upwards by 22.78% to $1.33. The market value of their outstanding shares is at $5.9 million.
  • China SXT Pharmaceuticals SXTC shares moved upwards by 22.61% to $1.2.

Losers

  • Neuronetics STIM stock declined by 33.1% to $2.51 during Tuesday's regular session. The company's market cap stands at $75.2 million. As per the news, the Q1 earnings report came out today.
  • Helius Medical Tech HSDT shares decreased by 25.62% to $1.8. The market value of their outstanding shares is at $1.5 million.
  • Allarity Therapeutics ALLR stock declined by 20.08% to $0.72. The market value of their outstanding shares is at $1.7 million.
  • Lyra Therapeutics LYRA stock fell 17.86% to $0.43. The market value of their outstanding shares is at $26.1 million.
  • GlucoTrack GCTK stock decreased by 16.28% to $0.64. The market value of their outstanding shares is at $17.1 million.
  • Talkspace TALK stock declined by 15.1% to $2.7. The company's market cap stands at $458.0 million. The company's, Q1 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!